These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17485918)

  • 1. Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: a comparison with thyroid cancer patients treated with radioiodine.
    Kinashi Y; Sakurai Y; Masunaga S; Suzuki M; Nagata K; Ono K
    J Radiat Res; 2007 May; 48(3):197-204. PubMed ID: 17485918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis.
    Joseph LJ; Bhartiya US; Raut YS; Kand P; Hawaldar RW; Nair N
    Mutat Res; 2009 Apr; 675(1-2):35-40. PubMed ID: 19386245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
    Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
    J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes.
    Livingston GK; Foster AE; Elson HR
    J Toxicol Environ Health; 1993; 40(2-3):367-75. PubMed ID: 8230307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
    Eberlein U; Scherthan H; Bluemel C; Peper M; Lapa C; Buck AK; Port M; Lassmann M
    J Nucl Med; 2016 Feb; 57(2):173-9. PubMed ID: 26564321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
    Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Välimäki P; Mäkitie A; Seppänen M; Minn H; Revitzer H; Kouri M; Kotiluoto P; Seren T; Auterinen I; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e67-75. PubMed ID: 21300462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of cytogenetic toxicity of low-dose radioiodine therapy in hyperthyroid patients using a micronuclei assay.
    Parida GK; Bal C; Dada R; Tripathi M; Dwivedi S
    Nucl Med Commun; 2016 Aug; 37(8):800-4. PubMed ID: 27081713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
    Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
    Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131.
    Dardano A; Ballardin M; Caraccio N; Boni G; Traino C; Mariani G; Ferdeghini M; Barale R; Monzani F
    Thyroid; 2012 Mar; 22(3):318-24. PubMed ID: 22181338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal carotid blowout syndrome after BNCT for head and neck cancers.
    Aihara T; Hiratsuka J; Ishikawa H; Kumada H; Ohnishi K; Kamitani N; Suzuki M; Sakurai H; Harada T
    Appl Radiat Isot; 2015 Dec; 106():202-6. PubMed ID: 26282568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival.
    Koivunoro H; Kankaanranta L; Seppälä T; Haapaniemi A; Mäkitie A; Joensuu H
    Radiother Oncol; 2019 Aug; 137():153-158. PubMed ID: 31108276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer.
    Vrndic O; Milosevic-Djordjevic O; Djurdjevic P; Jovanovic D; Mijatovic L; Jeftic I; Simonovic SZ
    Neoplasma; 2013; 60(5):568-75. PubMed ID: 23790177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
    S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer.
    González SJ; Pozzi ECC; Monti Hughes A; Provenzano L; Koivunoro H; Carando DG; Thorp SI; Casal MR; Bortolussi S; Trivillin VA; Garabalino MA; Curotto P; Heber EM; Santa Cruz GA; Kankaanranta L; Joensuu H; Schwint AE
    Phys Med Biol; 2017 Oct; 62(20):7938-7958. PubMed ID: 28858854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer.
    Fuwa N; Suzuki M; Sakurai Y; Nagata K; Kinashi Y; Masunaga S; Maruhashi A; Imahori Y; Kodaira T; Tachibana H; Nakamura T; Ono K
    Br J Radiol; 2008 Sep; 81(969):749-52. PubMed ID: 18541628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.